- •Dedication
- •Dedication
- •Preface
- •Contents
- •Contributors
- •Travel Awards
- •About the Editors
- •1.1 Introduction
- •1.2 Methods
- •1.2.1 RNA Preparation and cDNA Labeling
- •1.2.2 Hybridization of Slides, Image Acquisition and Bioinformatics
- •1.2.3 Real-Time PCR
- •1.3.2 Microarray Analysis of Bouse C Model
- •1.3.3 Microarray Analysis of MOT1 Mouse
- •1.4 Discussion
- •References
- •2 Regulation of Angiogenesis by Macrophages
- •2.1 Macrophage Polarization and Its Role in Angiogenesis
- •References
- •3.1 Introduction
- •3.2 Materials and Methods
- •3.2.1 Reagents
- •3.2.2 Animals and Retina Explant Culture
- •3.2.3 Cell Culture
- •3.2.4 Western Blot Assay
- •3.3 Results
- •3.3.1 Phorbol Esters Increase Rod Generation
- •3.3.2 Expression of PKC Isoforms in Developing Retina
- •3.3.3 Activation of PKC Decreases Phosphorylation of STAT3
- •References
- •4.1 Introduction
- •4.3 In Silico Information
- •4.4 Expression and Distribution in the Retina
- •4.5 Transmembrane Topology
- •4.6 Binding to PEDF Ligands
- •4.7 Phospholipase Activity
- •4.8 PEDF-R Activity in Retinal Cells
- •4.9 Conclusions
- •References
- •References
- •6 The Association Between Telomere Length and Sensitivity to Apoptosis of HUVEC
- •6.1 Introduction
- •6.2 Methods
- •6.2.1 The Culture of HUVEC and the Construction of Cell Division Model
- •6.2.2 Construction of an Apoptosis Model of HUVEC with Free Hydroxyl Radicals
- •6.2.3 Measurement of Apoptosis Rates and Telomere Lengths
- •6.2.4 Statistics Analysis
- •6.3 Results
- •6.3.1 Relationship Between the Time of Culture and the Telomere Length
- •6.3.2 Relationship Among Apoptosis Rates, Culture Times and Oxidation
- •6.3.3 Oxidation Enhances the Telomere Shortening
- •6.4 Discussion
- •References
- •7.1 Regulation of cGMP Levels in Photoreceptor Outer Segments
- •7.2 Retinal Disorders Associated with Mutations in RetGCs and PDE6
- •7.3 Analysis of Teleost RetGC and PDEs in Retinal Function and Disorders
- •References
- •8 RDS in Cones Does Not Interact with the Beta Subunit of the Cyclic Nucleotide Gated Channel
- •References
- •9.1 Introduction
- •9.2 Material and Methods
- •9.2.1 Animals
- •9.2.2 Methods
- •9.2.3 Statistical Analysis
- •9.3 Results
- •9.4 Discussion
- •References
- •10.1 Introduction
- •10.2 Methods and Results
- •10.2.1 ZBED4 mRNA is Expressed in Human Retina
- •10.2.2 ZBED4 mRNA is Expressed in Mouse and Human Cones
- •10.2.3 ZBED4 is Expressed Both in Nuclei and Cytoplasm of Human Cones
- •10.2.3.1 Human ZBED4 is Also Expressed in Müller Cells Endfeet
- •10.2.4 Human ZBED4 is Distributed Between Nuclear and Cytoplasmic Retinal Fractions
- •10.2.5 Subcellular Localization of ZBED4 in Stably Transfected Cells
- •10.3 Discussion
- •References
- •11 Tubby-Like Protein 1 (Tulp1) Is Required for Normal Photoreceptor Synaptic Development
- •11.1 Introduction
- •11.2 Methods
- •11.2.1 Animals
- •11.3 Results
- •11.4 Discussion
- •References
- •12.1 Introduction
- •12.2 Experimental Procedures
- •12.2.1 Animal
- •12.2.2 Immunohistochemistry
- •12.2.3 RT-PCR Analysis
- •12.2.4 Behavioral Analysis
- •12.3 Results
- •12.4 Discussion
- •12.4.2 GAP43 Is a Good Marker for Monitoring the Long Process of Optic Nerve Regeneration in Fish
- •References
- •13 Multiprotein Complexes of Retinitis Pigmentosa GTPase Regulator (RPGR), a Ciliary Protein Mutated in X-Linked Retinitis Pigmentosa (XLRP)
- •13.1 X-Linked RP (XLRP)
- •13.2 Retinitis Pigmentosa GTPase Regulator (RPGR)
- •13.3 RPGR Isoforms in the Retina
- •13.4 Animal Models of RPGR
- •13.5 Sensory Cilia
- •13.6 Retinal Degeneration Caused by Mutations in Ciliary Proteins
- •13.9 Conclusion
- •References
- •14 Misfolded Proteins and Retinal Dystrophies
- •14.1 Endoplasmic Reticulum Stress and Retinal Degeneration
- •14.2 Misfolded Proteins in Photoreceptors
- •14.3 Misfolded Proteins in Retinal Pigment Epithelial Cells
- •14.4 Pharmacologic Targeting of Protein Misfolding to Prevent Retinal Degeneration
- •References
- •15.1 Introduction
- •15.6 Perspective
- •References
- •16.1 Introduction
- •16.2 RCS Rat and MerTK Receptor: An Intimate Story
- •16.3 Changes Associated with Absence of MerTK in the Rat Retina
- •16.4 Daily Rhythmic Activation of Mertk: The Intracellular Way
- •16.5 The Debate About MerTK Ligands In Vivo
- •16.6 Perspectives
- •References
- •17.1 Introduction
- •17.3 Implications for IRBP and Cone Function
- •17.4 The Cone Visual Cycle
- •References
- •18.1 Introduction
- •18.2 Material and Methods
- •18.2.1 Reagents
- •18.2.2 Cell Culture
- •18.2.3 Flow Cytometry
- •18.3 Results
- •18.3.2 Oxidative Stress of Renal Tubular Epithelial Cells Does Not Alter Surface Expression of Crry by the Cells
- •18.4 Discussion
- •References
- •19 Role of Metalloproteases in Retinal Degeneration Induced by Violet and Blue Light
- •19.1 Introduction
- •19.2 Objective
- •19.3 Materials and Methods
- •19.4 Results
- •19.5 Conclusion
- •References
- •20.1 Summary
- •20.2 Introduction
- •20.3 Materials and Methods
- •20.3.1 Primary Human RPE Cell Culture
- •20.3.3 Mitochondrial Morphometrics
- •20.3.4 Protein and Weight Estimation of RPE Cells and Mitochondria
- •20.3.7 Expression of Mitochondrial Associated Genes
- •20.4 Results
- •20.4.1 Age Related Sensitivity of RPE Cells to Oxidative Stress
- •20.4.2 Variation in Mitochondrial Number, Structure, and Size
- •20.4.5 Expression of Genes Associated with Mitochondrial Function
- •20.5 Discussion
- •References
- •21 Ciliary Transport of Opsin
- •21.1 Introduction
- •21.2 Methods
- •21.3 Results
- •21.4 Discussion
- •References
- •22 Effect of Hesperidin on Expression of Inducible Nitric Oxide Synthase in Cultured Rabbit Retinal Pigment Epithelial Cells
- •22.1 Introduction
- •22.2 Materials and Methods
- •22.2.1 Preparing Hesperidin Extract of Pericarpium Citri Reticulatae
- •22.2.3 Cell Culture
- •22.2.4 MTT Cell Viability Assay
- •22.2.5 Assay of NO Production
- •22.2.6 Cellular Immunohistochemistry of iNOS
- •22.2.7 Statistical Analysis
- •22.3 Results
- •22.3.2 RPE Cells Morphology
- •22.3.4 Assay of NO and iNOS
- •22.4 Discussion
- •References
- •23.1 Introduction
- •23.2 Materials and Methods
- •23.2.1 Rabbit Retina Tissues
- •23.2.2 RNA Extraction
- •23.2.3 miRNA Microarray Analysis
- •23.2.4 Data Analysis
- •23.2.5 Bioinformatics Analysis of the Selected Mirnas
- •23.3 Results and Discussion
- •23.3.1 miRNA Microarray Analysis
- •23.3.2 Putative miRNA Target Gene Prediction
- •References
- •24.1 Introduction
- •24.2 Materials and Methods
- •24.2.1 Experiment with Animals
- •24.2.2 -Galactosidase Assay
- •24.3 Results
- •24.3.1 Generation of Transgenic Mice
- •24.3.2 Localization of Cre Function in Transgenic Mice
- •24.4 Discussion
- •References
- •25.1 Introduction
- •25.2 Methods
- •25.3 Result
- •25.4 Conclusions
- •References
- •26.1 PSC Proteins Involved in Inherited Retinal Degenerations
- •26.2 Structure of Photoreceptor Sensory Cilium Complex
- •26.3 Protein Components of Photoreceptor Sensory Cilium: PSC Proteome
- •26.4 Novel Photoreceptor Cilia Proteins in PSC Proteome
- •26.4.1 Subcellular Locations of Candidate Novel PSC Proteins
- •26.4.2 Functional Analysis of Novel PSC Proteins in Photoreceptor and Renal Cilia
- •26.4.2.1 shRNAs Against Novel PSC Genes
- •26.4.2.2 Evaluation of Phenotypes of shRNA Knockdown in mIMCD3 Cells and PSCs
- •26.5 TTC21B Protein in Photoreceptor Sensory Cilia and Renal Primary Cilia
- •26.5.1 TTC21B Localizes to the Basal Bodies and Transition Zone of Primary and Photoreceptor Sensory Cilia
- •26.5.2 TTC21B is Required for Primary Cilia and Photoreceptor Sensory Cilia Formation
- •26.6 Future Direction: Screening Novel PSC Genes for Mutations that Cause IRDs
- •References
- •27.1 Introduction
- •27.2 Materials and Methods
- •27.2.1 RNA Interference
- •27.2.2 Construction of Mouse Anti Elovl4 Gene shRNA
- •27.2.3 Tissue Culture
- •27.2.4 Fatty Acid Analysis
- •27.3 Results
- •27.3.1 661W Cells Express Elovl4 and Can Elongate 18:3n3 and 22:5n3 to Longer Chain Fatty Acids
- •27.4 Discussion
- •References
- •28 Molecular Pathogenesis of Achromatopsia Associated with Mutations in the Cone Cyclic Nucleotide-Gated Channel CNGA3 Subunit
- •28.1 Introduction
- •28.2 Materials and Methods
- •28.2.1 Constructs, Cell Culture and Transfection
- •28.2.3 Electrophysiological Recordings
- •28.2.4 SDS-PAGE and Western Blot Analysis
- •28.3 Results
- •28.3.1 The R218C and R224W Mutations Cause Loss of Channel Function
- •28.4 Discussion
- •References
- •29.1 Introduction
- •29.2 Materials and Methods
- •29.2.1 Patients and Ophthalmologic Examinations
- •29.2.2 Molecular Genetic Analysis
- •29.3 Results and Discussion
- •29.3.1 adRP
- •29.3.2 Bothnia Dystrophy
- •29.4 Conclusions
- •References
- •30.1 Introduction
- •30.2 Properties of Rhodopsin CSNB Mutants
- •30.2.1 Spectral and Photochemical Properties
- •30.2.2 Retinal Binding Kinetics of Rhodopsin CSNB Mutants
- •30.2.3 Activity of CSNB Mutants
- •30.2.3.1 In Vitro Assays of CSNB Mutants
- •30.2.3.2 Electrophysiological Studies on Transgenic Animal Models
- •30.3 Proposed Mechanisms of CSNB Mutations
- •30.3.1 Desensitization Due to Mutant Opsin Activity in Xenopus
- •30.3.2 Proposed Dark-Active Rhodopsin in Mouse
- •30.4 Future Studies
- •References
- •31 GCAP1 Mutations Associated with Autosomal Dominant Cone Dystrophy
- •31.2 Guanylate Cyclase 1 (GC1) and GCAP1
- •31.3 The EF Hand Motifs of GCAP1
- •31.5 EF3: The GCAP1(Y99C) and GCAP1(N104K) Mutations
- •31.6 EF4: The GCAP1(I143NT), GCAP1(L151F) and GCAP1(E155G) Mutations
- •31.7 Conclusion
- •References
- •32.1 Introduction
- •32.2 Methodology
- •32.2.1 Molecular Genetic Studies
- •32.2.2 Electrophysiological Studies
- •32.3 Results
- •32.3.1 RS1 Mutations in Western Australian Families
- •32.3.3.1 Family Information
- •32.3.3.2 Patient Information
- •32.3.3.3 Genetic Information
- •32.4 Discussion
- •References
- •33.1 Introduction
- •33.2 Materials and Methods
- •33.2.1 Subjects
- •33.2.2 DNA Extraction
- •33.2.4 RFLP Analysis
- •33.2.5 Statistical Analysis
- •33.3 Results
- •33.4 Discussion
- •References
- •34.1 Introduction
- •34.2 Materials and Methods
- •34.2.1 Animal Experiments and Experimental Groups
- •34.2.2 Web-Based siRNA Design Protocols Targeting Claudin-5
- •34.2.4 Indirect Immunostaining of Retinal Flatmounts
- •34.2.5 Assessment of BRB Integrity by Perfusion of Hoechst (H33342)
- •34.2.6 Magnetic Resonance Imaging (MRI)
- •34.3 Results
- •34.3.1 Claudin-5 Levels in Retinal Flatmounts
- •34.3.3 MRI Analysis of Ibrb Integrity Following Rnai of Claudin-5
- •34.4 Discussion
- •References
- •35 Spectral Domain Optical Coherence Tomography and Adaptive Optics: Imaging Photoreceptor Layer Morphology to Interpret Preclinical Phenotypes
- •35.1 Introduction
- •35.2 Materials and Methods
- •35.2.1 Subjects
- •35.2.2 Adaptive Optics Retinal Imaging
- •35.2.3 Spectral Domain Optical Coherence Tomography
- •35.3 Results
- •35.3.1 Cone Photoreceptor Mosaic Topography
- •35.3.2 Outer Nuclear Layer Thickness
- •35.4 Discussion
- •References
- •36.1 Introduction
- •36.2 Pharmacological Strategies for Misfolding Mutant Rod Opsin
- •36.2.1 Pharmacological Chaperones
- •36.2.2 Kosmotropes
- •36.2.3 Molecular Chaperone Inducers
- •36.2.4 Autophagy Inducers
- •36.3 Conclusion
- •References
- •37 Targeted High-Throughput DNA Sequencing for Gene Discovery in Retinitis Pigmentosa
- •37.1 Introduction
- •37.2 Methods
- •37.2.1 Selection of Families
- •37.2.2 VisionCHIP Gene Selection
- •37.2.3 VisionCHIP Validation
- •37.2.4 Evaluating Potentially Pathogenic Variants
- •37.3 Conclusion
- •References
- •38 Advances in Imaging of Stargardt Disease
- •38.1 Introduction
- •38.4 Adaptive Optics Scanning Laser Ophthalmoscope
- •38.5 Conclusion
- •References
- •39.1 Materials and Methods
- •39.1.1 Cell Culture
- •39.1.3 VEGF Expression was Determined by ELISA
- •39.1.4 Statistical Analysis
- •39.2 Results
- •39.2.1 The Maximum Inhibition of VEGF Expression by Protamine Sulfate
- •39.2.2 Protamine Sulfate Inhibits the RF/6A Cell VEGF Expression at the Hypoxic Condition
- •39.2.3 Protamine Sulfate Inhibits the Binding of VEGF to Its Receptor
- •39.3 Discussions
- •39.3.1 The Inhibition Effect of Protamine Sulfate on VEGF
- •39.3.2 Inhibition of the Binding Between VEGF and Its Receptor
- •39.3.3 The Potential Use of Protamine Sulfate Inhibition of Angiogenic Eye Diseases
- •References
- •40.1 Introduction
- •40.2 Methods
- •40.2.1 Immunohistochemial Staining of Choroidal Endothelia
- •40.2.2 Analysis of Choriodal Density with Photoshop 8.0
- •40.3 Results and Discussion
- •40.3.1 Analysis Of Choroidal Density
- •40.3.2 Usefulness of the Methodology
- •40.3.3 Summary
- •References
- •41 Thioredoxins 1 and 2 Protect Retinal Ganglion Cells from Pharmacologically Induced Oxidative Stress, Optic Nerve Transection and Ocular Hypertension
- •41.1 Introduction
- •41.2 Methods
- •41.2.1 Animals
- •41.2.2 RGC Counting
- •41.2.3 RGC Isolation
- •41.2.4 Western Blot Analysis
- •41.2.5 RGC-5 Culture and Transfection
- •41.2.6 Cell Viability Assay
- •41.2.7 In Vivo Electroporation (ELP)
- •41.2.8 Statistical Analysis
- •41.3 Results
- •41.3.1.1 TRX Expression in RGC-5 Cells in Response to Oxidative Stress
- •41.3.1.2 The Levels of TRX Proteins After ONT
- •41.3.1.3 The Levels of TRX Proteins After IOP Elevation
- •41.3.2 The Effect of TRX1 and TRX2 Overexpression on RGC Survival
- •41.3.2.2 TRX1 and TRX2 Overexpression Increases RGC Survival After ONT
- •41.3.2.3 TRX1 and TRX2 Overexpression Increases RGC Survival After IOP Elevation
- •41.4 Discussion
- •References
- •42 Near-Infrared Light Protect the Photoreceptor from Light-Induced Damage in Rats
- •42.1 Introduction
- •42.2 Material and Methods
- •42.2.1 Animal
- •42.2.2 Light Damage
- •42.2.3 670 nm LED Treatment
- •42.2.4 Evaluation of Photoreceptor Cell Function by Electroretinography
- •42.2.5 Morphological Evaluation of Photoreceptor Rescue by Quantitative Histology
- •42.2.6 Statistical Analysis
- •42.3 Results
- •42.3.1 LED Attenuated the Light Damage Area in Retinas
- •42.3.2 LED Protected the Morphology of Light Damage Retina
- •42.3.3 LED Protected the Function of Light Damage Retina
- •References
- •43.1 Introduction
- •43.2 Methods
- •43.2.1 Animals
- •43.2.2 Cell Preparation and Subretinal Transplantation
- •43.2.3 Flash-Electroretinogram (F-ERG) Recordings
- •43.2.5 Data Analysis
- •43.3 Results
- •43.3.1 ERG Amplitudes and Latencies
- •43.3.2 ONL Thickness
- •43.3.3 Graft Cells Survival After Subretinal Transplantation
- •43.4 Discussion
- •References
- •44.1 Introduction
- •44.2 Mechanisms of ATP Release and Degradation
- •44.2.1 ATP Release
- •44.2.2 Degradation of ATP
- •44.3 Purinergic Signaling in the Retina
- •44.3.1 Purinergic Modulation of Neuronal Signaling
- •44.3.2 ATP and Glial Transmission
- •44.4 The Role of Purinergic Receptors in Retinal Disease
- •44.5 Concluding Remarks
- •References
- •45.1 Background
- •45.3 FAF Findings in Early AMD with Drusen Only
- •45.4 FAF Findings in Late AMD with Geographic Atrophy
- •45.5 Progression of Geographic Atrophy
- •45.6 Mechanisms of Progression
- •45.7 Research to Prevent Progression
- •45.8 Discussion
- •References
- •46 Endoplasmic Reticulum Stress as a Primary Pathogenic Mechanism Leading to Age-Related Macular Degeneration
- •46.1 Age Related Macular Degeneration Is a Leading Cause of Vision Loss
- •46.3 ER Stress and Oxidative Stress Interact
- •46.5 Future Experimental Approaches
- •References
- •47 Proteomic and Genomic Biomarkers for Age-Related Macular Degeneration
- •47.1 Introduction
- •47.2 Methods
- •47.3 Results
- •47.3.1 CEP Adducts and Autoantibodies Are Elevated in AMD Plasma
- •47.3.2 AMD Risk Based on CEP Biomarkers and Genotype
- •47.3.3 The Association Between CEP Biomarkers and AMD Risk Genotypes
- •47.4 Discussion
- •References
- •48.1 Introduction
- •48.2 Methods
- •48.2.1 Chemicals
- •48.2.2 Establishment and Maintenance of hRPE Cell Cultures
- •48.2.3 Cellular Proliferation
- •48.2.4 Immunoprecipitation Assay
- •48.2.5 Statistical Analysis
- •48.3 Results
- •48.3.1 Effect of Glucose on 14C-CTGF Synthesis in hRPE Cells
- •48.3.2 Effect of IGF-1 on 14C-CTGF Synthesis in hRPE cells
- •48.4 Discussion
- •References
- •49.1 Introduction
- •49.1.3 Peroxisome Proliferator Activated Receptors (PPARs) are Expressed in ARPE19 Cells
- •49.2 LcPUFA Regulates Gene Expression in ARPE19 Cells
- •49.2.1 Purpose and Methods
- •49.2.2 Results
- •49.2.3 Discussion
- •References
- •50.1 Introduction
- •50.2 Cigarette Smoking as a Risk Factor for AMD
- •50.2.1 AMD and Cigarette Smoke
- •50.2.2 Cigarette Smoke Constituents
- •50.3 Oxidative Stress
- •50.3.1 Oxidative Damage in AMD
- •50.3.2 Reactive Oxygen Species in Cigarette Smoke
- •50.3.3 Acrolein-Induced Oxidative Stress
- •50.3.4 Cadmium-Induced Oxidative Stress
- •50.4 Cigarette Smoke Depletion of Antioxidant Protection
- •50.4.1 Systemic Antioxidant Mechanisms
- •50.4.2 Local Ocular Antioxidants
- •50.5 Non-oxidative Chemical Damage by Cigarette Smoke
- •50.5.1 Nicotine
- •50.5.2 Polycyclic Aromatic Hydrocarbons
- •50.6.2 Cigarette Smoke and Complement Pathway
- •50.7 Vascular Changes
- •50.8 Conclusions
- •References
- •51.1 Oxidative Stress and Age-Related Macular Degeneration
- •51.2 The Ubiquitin Proteolytic System (UPS) and Oxidative Stress in the Retina
- •51.3 The UPS and the Cytoprotective Transcription Factor, Nrf2
- •References
- •52 Slit-Robo Signaling in Ocular Angiogenesis
- •52.1 Ocular Angiogenesis
- •52.2 Slit-Robo Signaling in Axon Guidance
- •52.3 Slit-Robo Signaling in Angiogenesis
- •52.4 Slit-Robo Signaling in Ocular Angiogenesis
- •52.5 Signaling Pathway of Slit-Robo System in Angiogenesis
- •52.6 Perspective
- •References
- •53.1 Introduction
- •53.2 Materials and Methods
- •53.2.1 Animals and Biosafety
- •53.2.2 MNU-Induced Retinal Degeneration
- •53.2.3 Electroretinography
- •53.2.4 Histological Examination and Immunohistochemistry
- •53.3 Results
- •53.3.1 Fundus Examination and Histology of the Retina
- •53.3.3 BrdU Incorporation
- •53.3.4 Immunohistology of Nestin
- •References
- •54 Differences in Photoreceptor Sensitivity to Oxygen Stress Between Long Evans and Sprague-Dawley Rats
- •54.1 Introduction
- •54.2 Methods
- •54.2.1 Animal Strains and Oxygen Exposure
- •54.2.2 Electroretinography
- •54.2.3 Immunohistochemistry and TUNEL Labeling
- •54.3 Results
- •54.3.1 Rod and Cone Components of the ERG after Hyperoxia
- •54.3.2 Impact of Hyperoxia on the Rate of Photo receptor Death
- •54.3.3 Impact of Hyperoxia on GFAP Expression
- •54.4 Discussion
- •References
- •55.1 Introduction
- •55.2 The AY9944 Rat Model of SLOS: Biochemical Findings
- •55.3 Retinal Degeneration in the SLOS Rat Model: Histology and Ultrastructure
- •References
- •56.1 Introduction
- •56.1.1 The Pde6brd1 Mouse and Increased [cGMP]
- •56.1.2 Calcium Regulation and Overload in the Photoreceptor Inner Segment
- •56.2 D-cis-diltiazem and Neuroprotection in the Retina
- •56.2.1 Criticism of the Frasson Study
- •56.3 Other Players May Be Involved
- •References
- •57.1 Introduction
- •57.2 Materials and Methods
- •57.2.1 Animals and Reagents
- •57.2.2 Induction of Retinal I/R
- •57.2.4 Statistical Analysis
- •57.3 Results
- •57.3.1 Effect of PBNA on Serum NO Content in Retinal I/R Injury
- •57.3.2 Effect of PBNA on T-NOS Activity in Retinal I/R Injury
- •57.3.3 Effect of PBNA on iNOS Activity in Retinal I/R Injury
- •57.3.4 Effect of PBNA on Serum eNOS Activity in Retinal I/R Injury
- •57.4 Discussion
- •References
- •References
- •59.1 Introduction
- •59.2 Materials and Methods
- •59.2.1 Experimental Animals
- •59.2.3 Construction of the pur-GFP Reporter Vector
- •59.2.4 Morpholino and Microinjections
- •59.2.5 In Situ Hybridization
- •59.2.6 RNA Isolation, RT-PCR and mRNA Synthesis
- •59.3 Results
- •59.3.2 Similar Phenotypes of Purpurin and Crx Morphant
- •References
- •60.1 Introduction
- •60.2 Bipolar Cell Function in Retinal Degeneration
- •60.2.1 Glutamate Receptors of Bipolar Cells in the Normal and Degenerating Retina
- •60.2.2 Evidence for Bipolar Cell Dysfunction
- •60.2.2.1 Rod Bipolar Cells
- •60.2.2.2 Cone Bipolar Cells
- •60.3 Ganglion Cell Function in Retinal Degeneration
- •References
- •61.1 Introduction
- •61.2 Methods
- •61.2.1 Animals and Rearing
- •61.2.2 Measurement of Outer Nuclear Layer Thickness
- •61.2.3 Counting Photoreceptor Nuclei
- •61.3 Results
- •61.4 Discussion
- •References
- •62.1 Introduction
- •62.2 Retinitis Pigmentosa
- •62.4 IMPDH Structure and Function
- •62.5 IMPDH Binds Single Stranded Nucleic Acids
- •62.6 Retinal Isoforms of IMPDH1
- •62.7 Kinetic and Nucleic Acid Binding Properties of Retinal IMPDH1
- •62.8 Conclusion
- •References
- •63.1 Introduction
- •63.2 Methods
- •63.3 Results
- •63.4 Discussion
- •63.5 Conclusion
- •References
- •64.1 Introduction
- •64.2 Results
- •64.2.1 Evaluation of Optimal IMPDH1 Suppressors
- •64.2.2 RP10 Mouse Model
- •64.3 Discussion
- •References
- •65 Correlation Between Tissue Docosahexaenoic Acid Levels and Susceptibility to Light-Induced Retinal Degeneration
- •65.1 Introduction
- •65.2 Methods
- •65.3 Results
- •65.4 Discussion
- •References
- •66.1 Introduction
- •66.2 Materials and Methods
- •66.2.1 Animal
- •66.2.2 Immunohistochemical Staining
- •66.2.3 Western Blot Test
- •66.2.4 Müller Cell Cultures
- •66.2.5 Data Analysis
- •66.3 Results
- •66.3.1 Morphology and Quantity Changes of Müller Cells
- •66.3.2 Expression of GFAP and ERK in RCS Rat Müller Cells
- •66.3.3 Effect of Mixed Retinal Cells of RCS Rats on Normal Müller Cells
- •66.4 Discussion
- •References
- •67.1 Introduction
- •67.2 Materials and Methods
- •67.2.1 Animals and Reagents
- •67.2.2 Induction of RI/R
- •67.2.4 Statistical Analysis
- •67.3 Results
- •67.3.1 The Effect of DSS on the Concentration of MDA in Serum After RI/R Injury
- •67.3.2 The Effect of DSS on the Activity of SOD in Serum After RI/R Injury
- •67.3.4 The Effect of DSS on the Concentration of Serum NO After RI/R Injury
- •67.4 Discussion
- •References
- •68.1 Introduction
- •68.2 Materials and Methods
- •68.2.1 Animals
- •68.2.2 Functional Testing
- •68.2.3 In Vivo Imaging
- •68.3 Results
- •68.3.1 Function
- •68.3.2 Morphology
- •68.4 Discussion
- •References
- •69.1 Introduction
- •69.2 Materials and Methods
- •69.2.1 Mice and Light Exposure
- •69.3 Results
- •69.3.3 Jak3 mRNA Is Induced Similarly in the Model of Light Induced Photoreceptor Cell Death and the rd1 Mouse Model
- •69.4 Discussion
- •References
- •70.1 Introduction
- •70.2 Diseases Associated with RDS Mutations
- •70.3 Current Animal Models
- •70.4 Gene Therapy in rds Models
- •70.5 Viral Gene Therapy Approaches
- •70.6 Non-viral Approaches
- •References
- •71.1 Introduction
- •71.2 Materials and Methods
- •71.2.1 Retinal Stem Cell Isolation and Culture
- •71.2.2 Single Sphere Passaging
- •71.2.3 Bromodeoxyuridine Labeling
- •71.2.4 Retinal Stem Cell Differentiation
- •71.3 Results
- •71.3.2 Retinal Neurosphere Proliferation
- •71.3.3 Differentiation of Retinal Cells Precursors from RSCs
- •71.4 Discussion
- •References
- •72 A Multi-Stage Color Model Revisited: Implications for a Gene Therapy Cure for Red-Green Colorblindness
- •72.1 Introduction
- •72.2 A Brief History of Color Vision Theory
- •72.3 Color Vision from an Evolutionary Perspective
- •References
- •73 Achromatopsia as a Potential Candidate for Gene Therapy
- •73.1 Human Achromatopsia
- •73.1.1 Clinical Manifestations
- •73.1.2 Current Achromatopsia Treatments
- •73.2 Genetics of Human Achromatopsia
- •73.2.1 GNAT2 Achromatopsia
- •73.2.2 CNG Achromatopsia
- •73.2.3 Achromatopsia Gene Therapy
- •73.3 The Mutant Gnat2 Mouse and Gene Therapy
- •73.3.1 The Cnga3 Mutant Mouse and Gene Therapy
- •73.3.2 The Cngb3 Mutant Dog and Gene Therapy
- •73.4 Prospects for Achromatopsia Gene Therapy
- •References
- •74.1 Introduction
- •74.2 Effects of CNTF/LIF on Photoreceptor and Bipolar Neuron Differentiation
- •74.3 Effects of CNTF/LIF on Muller Glia Genesis and Late Progenitor Proliferation
- •74.4 Effects of LIF Misexpression on Retinal Vasculature Development
- •74.5 Expression of CNTF/LIF Signaling Components in the Developing Retina
- •74.6 Signaling Events Triggered by CNTF/LIF During Retinogenesis
- •74.7 CNTF/LIF Regulate Numerous Genes Involved in Retinogenesis
- •74.8 Perspective
- •References
- •75.1 Introduction
- •75.4 Discussion
- •References
- •76.1 The Importance of RPE Cell Function and Integrity for Photoreceptor Survival
- •76.2 The Loss of RPE Cells in Retinal Degeneration
- •76.3 DHA and NPD1 Properties and Neuroprotection
- •References
- •77 Adeno-Associated Virus Serotype-9 Mediated Retinal Outer Plexiform Layer Transduction is Mainly Through the Photoreceptors
- •77.1 Introduction
- •77.2 AAV9-Mediated Gene Transfer in the Retina
- •77.5 Subretinal Injection of AAV9 Vector Did Not Cause Acute Retinal Damage
- •77.6 Conclusions
- •References
- •Index
240 |
M.-P. Agbaga et al. |
the same way as in the wild-type cells. These elongation steps could be mediated by the 5–7 elongase activity of the mouse ELOVL2 protein (Meyer et al., 2004). Elongation of 20:5n3 to 22:5n3 was also probably catalyzed by 5 elongase activity of the same enzyme (Meyer et al., 2004). This suggests ELOVL4 may not be involved in elongation of these steps in the pathway of 22:6n3 biosynthesis. We then evaluated 7 elongase activity in the pathway of 22:6n3 biosynthesis by incubating the cells with 22:5n3 while knocking down the expression of Elovl4. ELOVL4 knock-down did not have any effect on the elongation of 22:5n3 to 24:5n3 (data not shown). We, therefore, concluded that the ELOVL4 protein could either be playing a redundant role in biosynthesis of 22:6n3 or it may not be involved in the biosynthesis of 22:6n3 in the retina or in any tissues where it is expressed. These conclusions are also supported by recent studies on ELOVL4 using different mouse models (Cameron et al., 2007; Li et al., 2007; McMahon et al., 2007a, b; Vasireddy et al., 2007). Further, we designed experiments to test the hypothesis that the ELOVL4 protein is involved in synthesizing C26–C38 Very Long Chain Polyunsaturated Fatty Acids (VLC-PUFA), which are also found in ELOVL4 expressing tissues in minor quantities (Aveldano 1987). We presented an unequivocal evidence that indeed the ELOVL4 protein is involved in the biosynthesis of VLC-PUFA (Agbaga et al., 2008). The findings that ELOVL4 is involved in the biosynthesis of VLCPUFA are in agreement with previous studies that showed that the skin of mice homozygous for Elovl4 5-bp deletion knock-in and Elovl4 knock-out animals have greater total saturated FA (esp. 24:0 and 26:0) than that of their wild-type kin (Cameron et al., 2007; Li et al., 2007; McMahon et al., 2007a; Vasireddy et al., 2007). It also supported the studies by McMahon et al. (2007b) which showed that the retinas of Stgd3-knockin mice that carry one copy of the human pathogenic 5-bp deletion in the mouse Elovl4 gene and one normal copy of the mouse Elovl4 gene have deficiency in C32-C36 acyl phosphatidylcholine. Moreover, the 22:6n3 composition of those retinas was not different from the composition of the retinas from wild-type mice (McMahon et al., 2007b). The conclusion drawn from the current study is that ELOVL4 is not involved in the biosynthesis of 22:6n3 from shorter chain PUFA precursors.
Acknowledgments We thank Kimberly Henry for her technical support. This work was supported by National Eye Institute Grants EY04149, EY00871, and EY12190; National Center for Research Resources Grant RR17703; Research to Prevent Blindness, Inc., R01EY14052, Hope For Vision, Reynolds Oklahoma Center on Aging; and the Foundation Fighting Blindness.
References
Agbaga MP, Brush RS, Mandal MN et al (2008) Role of Stargardt-3 macular dystrophy protein (ELOVL4) in the biosynthesis of very long chain fatty acids. Proc Natl Acad Sci USA 105:12843–12848
Al-Ubaidi MR, Font RL, Quiambao AB et al (1992) Bilateral retinal and brain tumors in transgenic mice expressing simian virus 40 large T antigen under control of the human interphotoreceptor retinoid-binding protein promoter. J Cell Biol 119:1681–1687
Aveldano MI (1987) A novel group of very long chain polyenoic fatty acids in dipolyunsaturated phosphatidylcholines from vertebrate retina. J Biol Chem 262:1172–1179
27 Role of Elovl4 Protein in the Biosynthesis of Docosahexaenoic Acid |
241 |
Bazan HE, Careaga MM, Sprecher H et al (1982) Chain elongation and desaturation of eicosapentaenoate to docosahexaenoate and phospholipid labeling in the rat retina in vivo. Biochim Biophys Acta 712:123–128
Benolken RM, Anderson RE, Wheeler TG (1973) Membrane fatty acids associated with the electrical response in visual excitation. Science 182:1253–1254
Bernstein PS, Tammur J, Singh N et al (2001) Diverse macular dystrophy phenotype caused by a novel complex mutation in the ELOVL4 gene. Invest Ophthalmol Vis Sci 42:3331–3336
Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911–917
Cameron DJ, Tong Z, Yang Z et al (2007) Essential role of Elovl4 in very long chain fatty acid synthesis, skin permeability barrier function, and neonatal survival. Int J Biol Sci 3:111–119 DeMar JC Jr, Anderson RE (1997) Identification and quantitation of the fatty acids composing the
CoA ester pool of bovine retina, heart, and liver. J Biol Chem 272:31362–31368
DeMar JC Jr, Wensel TG, Anderson RE (1996) Biosynthesis of the unsaturated 14-carbon fatty acids found on the N termini of photoreceptor-specific proteins. J Biol Chem 271:5007–5016
Delton-Vandenbroucke I, Grammas P, Anderson RE (1997) Polyunsaturated fatty acid metabolism in retinal and cerebral microvascular endothelial cells. J Lipid Res 38:147–159
Edwards AO, Donoso LA, Ritter R 3rd (2001) A novel gene for autosomal dominant Stargardtlike macular dystrophy with homology to the SUR4 protein family. Invest Ophthalmol Vis Sci 42:2652–2663
Grayson C, Molday RS (2005) Dominant negative mechanism underlies autosomal dominant Stargardt-like macular dystrophy linked to mutations in ELOVL4. J Biol Chem 280:32521– 32530
Karan G, Yang Z, Howes K et al (2005) Loss of ER retention and sequestration of the wild-type ELOVL4 by Stargardt disease dominant negative mutants. Mol Vis 11:657–664
Leonard AE, Pereira SL, Sprecher H et al (2004) Elongation of long-chain fatty acids. Prog Lipid Res 43:36–54
Li W, Sandhoff R, Kono M et al (2007) Depletion of ceramides with very long chain fatty acids causes defective skin permeability barrier function, and neonatal lethality in ELOVL4 deficient mice. Int J Biol Sci 3:120–128
McMahon A, Butovich IA, Mata NL et al (2007a) Retinal pathology and skin barrier defect in mice carrying a Stargardt disease-3 mutation in elongase of very long chain fatty acids-4. Mol Vis 13:258–272
McMahon A, Jackson SN, Woods AS et al (2007b) A Stargardt disease-3 mutation in the mouse Elovl4 gene causes retinal deficiency of C32-C36 acyl phosphatidylcholines. FEBS Lett 581:5459–5463
Meyer A, Kirsch H, Domergue F et al (2004) Novel fatty acid elongases and their use for the reconstitution of docosahexaenoic acid biosynthesis. J Lipid Res 45:1899–1909
Morrison WR, Smith LM (1964) Preparation of Fatty Acid Methyl Esters and Dimethylacetals from Lipids with Boron Fluoride–Methanol. J Lipid Res 5:600–608
Salem N Jr, Litman B, Kim HY et al (2001) Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 36:945–959
Sprecher H (1999) An update on the pathways of polyunsaturated fatty acid metabolism. Curr Opin Clin Nutr Metab Care 2:135–138
Sprecher H (2000) Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim Biophys Acta 1486:219–231
Sprecher H, Chen Q, Yin FQ (1999) Regulation of the biosynthesis of 22:5n-6 and 22:6n-3: a complex intracellular process. Lipids 34(Suppl):S153–S156
Tanito M, Brush RS, Elliott MH et al (2008) High levels of retinal membrane docosahexaenoic acid increase susceptibility to stress-induced degeneration. J Lipid Res 50(5):807–819
Tvrdik P, Westerberg R, Silve S et al (2000) Role of a new mammalian gene family in the biosynthesis of very long chain fatty acids and sphingolipids. J Cell Biol 149:707–718
242 |
M.-P. Agbaga et al. |
Vasireddy V, Uchida Y, Salem N Jr et al (2007) Loss of functional ELOVL4 depletes very longchain fatty acids (> or =C28) and the unique omega-O-acylceramides in skin leading to neonatal death. Hum Mol Genet 16:471–482
Vasireddy V, Vijayasarathy C, Huang J et al (2005) Stargardt-like macular dystrophy protein ELOVL4 exerts a dominant negative effect by recruiting wild-type protein into aggresomes. Mol Vis 11:665–676
Voss A, Reinhart M, Sankarappa S et al (1991) The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturase. J Biol Chem 266:19995–20000
Westerberg R, Tvrdik P, Unden AB et al (2004) Role for ELOVL3 and fatty acid chain length in development of hair and skin function. J Biol Chem 279:5621–5629
Zhang K, Kniazeva M, Han M et al (2001) A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy. Nat Genet 27:89–93
Part II
Molecular Genetics and Candidate Genes
